Tapemark manufacturing facility completes successful FDA pre-approval and general GMP inspection. St. Paul, Minn., June 5, 2017 – The FDA has completed a successful pre-approval inspection (PAI) of Tapemark’s manufacturing process and a general good manufacturing practices (GMP) inspection. The pre-approval inspection assessed Tapemark’s readiness to commercially manufacture one of its customer’s transdermal pharmaceutical products…